Delivering Targeted Therapy for Cardiac Arrhythmias
CardioNXT is building a platform of products that enable a better understanding of complex cardiac arrhythmias such as Atrial Fibrillation, and furthermore deliver targeted therapy to affected areas within the heart. In addition to providing next generation technology, CardioNXT products are designed to reduce the cost of cardiac catheter ablation procedures. This attention to cost reduction will not only benefit the U.S. market, it will enable arrhythmia therapies to be adopted rapidly in global markets including underserved emerging markets.
CardioNXT was founded in 2012 in Westminster, CO with the core belief that great things can be achieved when Doctors and Engineers work closely together.
Prior to co-founding CardioNXT, Mr. Edwards led the software development of LOCALISA for Medtronic. LOCALISA eventually turned into the market leading product called Ensite NavX, now owned by St. Jude Medical. Edwards also founded Veran Medical Technologies, Inc. to develop lung navigation systems for the diagnosis and treatment of lung cancer. Veran has raised over $125M in financing and is now a commercial stage company growing revenues over 50% per year. Edwards holds a B.S. in Engineering with honors and an M.B.A. as a Dean’s Scholar from the Colorado School of Mines and Vanderbilt University respectively. Edwards holds over fifty issued and pending patents
Mr. Kessman led the electronics development of LOCALISA and AxiEM electromagnetic tracking technology for Medtronic. Kessman is one of six co-founders of Stealth Technologies, now a $400MM revenue per year business unit known as Medtronic-Navigation located outside Boulder, CO. Kessman holds an M.S. and B.S. in Electrical Engineering from Southern Illinois University.
Dr. Kurian completed his cardiac electrophysiology fellowship at Washington University – Barnes Jewish Hospital. Kurian is a practicing cardiac electrophysiologist at Seton Heart Institute in Austin, TX. Kurian holds an M.D. from University of Texas Medical School – Houston and a B.S. (Biochemistry) from University of Dallas. Dr. Kurian was the first clinician to test and help implement Phase Synchronization Mapping of Atrial Fibrillation.
Conty manages the finances of CardioNXT and serves as in-house General Counsel. He holds a J.D. from Marquette University and a B.S. in Finance from the University of Colorado.
Nguyen obtained his B.S. in Physics and M.S. in Electrical Engineering at the Colorado School of Mines. Nguyen has completed all coursework towards a Ph.D. and is currently defending his dissertation in Computer Vision, also at the Colorado School of Mines. Nguyen is the inventor of Phase Synchronization Mapping of Atrial Fibrilation.
Mackin has over 17 years of experience managing Operations, Logistics and Customer Service with Bose, Dell and Apple Corporations. Mackin holds a B.S. from Colorado State University.
CardioNXT considers all applicants without regard to race, color, religion, creed, gender, national origin, age, disability, marital or veteran status, or any other legally protected status. Our policies regarding recruitment, hiring, compensation, benefits, promotions, transfers, training and all other personnel matters are free from discriminatory practices.
Please Submit resumes to email@example.com
9035 Wadsworth Pkwy, Suite 3400. Westminster CO 80021 United States
Copyright © 2019 CardioNXT, Inc. - All Rights Reserved.